Unbound MEDLINE

Characterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice. Pharmacological reports : PR [Pharmacol Rep] Journal article

 
TitleCharacterization of acute adverse-effect profiles of selected antiepileptic drugs in the grip-strength test in mice.
Author(s)Zadrozniak A, Wojda E, Wlaź A, Luszczki JJ 
InstitutionDepartment of Pathophysiology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland. jluszczki@yahoo.com; jarogniew.luszczki@gmail.com.
SourcePharmacol Rep 2009 Jul-Aug; 61(4):737-42.
AbstractThe aim of this study was to assess the acute adverse effects (neurotoxic) of several antiepileptic drugs (clonazepam, lamotrigine, oxcarbazepine, phenytoin, phenobarbital and topiramate) by measuring skeletal muscular strength in mice using the grip-strength test. Linear regression analysis of grip-strength in relation to drug dose-response allowed us to determine D(50) values, the dosages of antiepileptic drugs that reduced grip-strength in mice by 50% compared to control animals. Each of the antiepileptic drugs studied reduced skeletal muscular strength in mice in a dose-dependent manner. The D(50) for clonazepam was 31.7 mg/kg, lamotrigine - 47.7 mg/kg, oxcarbazepine - 87.3 mg/kg, phenobarbital - 128.7 mg/kg, phenytoin - 69.7 mg/kg, and topiramate - 509.5 mg/kg. In conclusion, the grip-strength test can aid in evaluating acute adverse effects of drugs with respect to their influence on muscular strength in experimental animals.
Languageeng
Pub Type(s)Journal Article
PubMed ID19815958
  
Advertise on this site.